Atlas Trials

Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

Clinical trial NCT04896528 · UNKNOWN

Trial details

NCT number
NCT04896528
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
ThrombocytopeniaAvatrombopag
Start date
2021-06-06
Primary completion
2021-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.